جستجوی استاد راهنمای دانشگاهی

• Health services research
• Implementation science
• Patient-reported outcomes
• +۶ مورد دیگر

Rachel Hess, MD, MS is Professor of Population Health Sciences and Internal Medicine and Associate Vice President for Research-Health Sciences at the University of Utah Schools of the Health Sciences. She co-directs the Utah Clinical and Translational Science Institute and was founding Chief of the Division of Health System Innovation and Research (2014-2022). A board-certified General Internist and internationally recognized health-services researcher, she focuses on translating evidence into practice through health-information technology and patient-centered outcomes. Education & Training MD – University of New Mexico School of Medicine MS Clinical Research – University of Pittsburgh Fellowship – General Internal Medicine & Women’s Health, University of Pittsburgh / VA Pittsburgh Medical Center Chief Residency – Internal Medicine, Western Pennsylvania Hospital Residency – Internal Medicine, Temple University Hospital BA Mathematics – Washington University in St. Louis Research Focus Dr Hess’s program is dedicated to improving patient-centered outcomes by leveraging implementation science, health-information technology, and patient-reported measures. Her work spans: Design and nationwide deployment of EHR-integrated clinical decision support for cancer genetics, lung-cancer screening, heart-failure management, and antibiotic stewardship. Large multi-site pragmatic trials (ADAPTABLE, RECOVER, BRIDGE, MAINTAIN) examining effectiveness, equity, and scalability of digital-health interventions. Women’s health across the lifespan, including studies on menopause, sexual function, and post-COVID sequelae. Advanced analytics linking patient-reported outcomes (PROs) with healthcare utilization and cost. Scientific Awards & Recognition Board Certification, American Board of Internal Medicine (Internal Medicine) Leadership of NIH RECOVER Consortium adult cohort—one of the largest studies of Long COVID worldwide Principal investigator on >$50 million in federal and foundation funding (PCORI, NHLBI, NCI, AHRQ, CDC) Leadership & Service As Associate Vice President for Research she sets strategic priorities for the Schools of Medicine, Nursing, Pharmacy, Dentistry, and Health. She co-chairs the Utah Clinical and Translational Science Institute, oversees campus-wide clinical-trials infrastructure, and mentors interdisciplinary teams spanning informatics, behavioral science, epidemiology, and clinical medicine. Laboratories & Teams Dr Hess leads the Health System Innovation and Research (HSIR) group—an interdisciplinary unit of data scientists, implementation researchers, clinicians, and patient partners—dedicated to rapid-cycle testing and national scale-up of digital-health solutions.

• Autism Spectrum Disorder
• Biostatistical Methods
• Chronic disease
• +۴ مورد دیگر

Xiaoyu Che is an Assistant Professor of Biostatistics at Columbia University's Mailman School of Public Health, where he serves as the principal biostatistician in the Center for Infection and Immunity (CII) at Columbia University Irving Medical Center. His work bridges statistical methodology with biomedical research, focusing on complex disease mechanisms through advanced data analysis approaches. Dr. Che received his academic training at prestigious institutions: BS in Mathematics from Zhejiang University (2006) PhD in Mathematics from Claremont Graduate University (2013) Dr. Che's research program centers on the development and application of statistical methods for multi-omics analyses, with particular focus on understanding the pathogenesis of chronic and neurodevelopmental conditions. His work spans multiple domains including Autism Spectrum Disorder (ASD), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Gulf War Illness (GWI). He employs sophisticated biostatistical approaches to integrate diverse biological data types, revealing novel insights into disease mechanisms. His methodological expertise includes Bayesian statistics, metabolomic analysis, immune signature identification, and microbiome characterization, all aimed at translating complex biological data into meaningful clinical insights. Analysis of Dr. Che's publication record reveals a strong thematic focus on applying advanced statistical methods to understand complex disease mechanisms. His work consistently bridges biostatistical innovation with biomedical discovery, particularly in the areas of neurodevelopmental disorders and chronic fatigue conditions. The publications demonstrate progression from foundational methodological work to increasingly sophisticated multi-omics integration approaches, reflecting both technical growth and expanding research impact. His collaborative approach is evident through numerous high-impact publications with interdisciplinary teams across Columbia University and beyond. Dr. Che teaches BIST P8104: Probability in the Biostatistics MS degree program at Columbia, demonstrating his commitment to training the next generation of biostatisticians. While specific grant information isn't detailed in the provided materials, his extensive publication record across multiple high-impact journals suggests successful grant funding supporting his research program. As principal biostatistician in the Center for Infection and Immunity, Dr. Che plays a critical role in the analytical framework of the center's research initiatives. His work supports the center's mission to understand the relationship between infectious agents and human health through rigorous quantitative analysis. The collaborative nature of his research is evident in the diverse range of co-authors spanning immunology, virology, microbiology, and clinical medicine.

Sarah Petersمشاهده پروفایل

استاد

• Healthcare Communication
• Qualitative Research Methods
• Psychological Interventions
• +۵ مورد دیگر

Sarah Peters is a Professor in Psychology within the Division of Psychology & Mental Health at the University of Manchester's Faculty of Biology, Medicine & Health. She currently serves as Co-Director of the Equity, Diversity and Inclusivity Research Unit (EDI-RU) GMH (2021 to date) and was previously Director of the Manchester Centre for Health Psychology (2021 to 2025). She also leads the Greater Manchester qualitative and health psychology stream of the NorthWest NIHR Research Design Service. Her research focuses on healthcare communication, particularly within challenging contexts such as medically unexplained symptoms, unhealthy behaviours and suicide. The goal of her work is to improve patient care through equipping health professionals to communicate more effectively with patients, relatives and colleagues. She specializes in integrating qualitative methods within randomised controlled trials to examine mechanisms of action, acceptability, feasibility and implementation of psychological and educational interventions. Her recent publications demonstrate strong trends in qualitative methodologies applied to healthcare communication challenges across diverse populations including older adults in primary care, postpartum women with eating disorders, culturally diverse patient groups, and individuals with chronic conditions. Her work consistently emphasizes patient-centered communication and the development of practical interventions to improve clinical interactions. Professor Peters serves on editorial boards for prestigious journals including the British Journal of Psychiatry, Social Science and Medicine, British Journal of Health Psychology, and Psychology & Psychotherapy: Theory, Research and Practice. She previously served as External Examiner for the MSc Health Psychology program at St Andrews. She has supervised 38 doctoral students to completion and currently mentors 8 doctoral candidates working on diverse topics including laryngeal hypersensitivity, pain communication in children, ethnic diversity in health research, therapeutic alliance in online therapy, cultural differences in primary care, language of 'Teachable Moments' in midwifery, postnatal behavior change conversations, and suicide research guidelines. Professor Peters leads research within the Manchester Centre for Health Psychology and is actively involved in multiple research projects including the STAR study focusing on chronic musculoskeletal pain in children, NIHR Research Support Service, and BART II investigating cognitive behavioral therapy for young adults at high risk of developing bipolar disorder.

• Digital Transformation
• Healthcare Informatics
• Artificial Intelligence
• +۶ مورد دیگر

Dr. Amir Andargoli is a Senior Lecturer in Information Systems at Swinburne University of Technology's School of Business, Law and Entrepreneurship. His research focuses on digital transformation, healthcare innovation, and strategic information management. He has published extensively in journals like Journal of Strategic Information Systems and Information & Management, with a particular emphasis on digital ecosystems, blockchain in healthcare, and AI applications. Research Interests: Dr. Andargoli's work bridges information systems theory with practical applications in healthcare and industry. His recent projects explore digital twins for dementia care, blockchain architectures for healthcare data sharing, and the socio-technical dynamics of Lean management systems. He emphasizes user-centered design in digital technologies to enhance organizational value and patient outcomes. Grants & Projects: He has secured grants from institutions including the Australian Academy of Science and Barbara Dicker Brain Science Foundation. Notable projects include examining Spotify's algorithmic playlists (Contemporary Music Victoria), developing digital solutions for ME/CFS care (Emerge Australia), and conceptualizing digital twins for dementia care (Ian Dicker Family Settlement). Teaching & Supervision: Dr. Andargoli teaches in Swinburne's Business Information Systems programs and supervises Higher Degree by Research candidates. His supervision focuses on topics like data governance, digital innovation in supply chains, and psychological safety in digital transformation projects. He has advised on doctoral theses addressing healthcare resilience, suicide helpline systems, and digital transformation in post-pandemic contexts. Professional Recognition: He is a 2011 finalist in Griffith University's Innovation Challenge for the A-SOSim project. His research has been cited in leading conferences like the Hawaii International Conference on System Sciences and Bled eConference.

• Chronic Pain
• Chronic Fatigue Syndrome
• Epigenomics
• +۴ مورد دیگر

Andrea Polli is an unpaid and external employee in the Department of Physiotherapy, Human Physiology and Anatomy at Vrije Universiteit Brussel (VUB), Belgium, with an ORCID profile (0000-0001-8559-2217). She maintains an active research profile with 53 documented research outputs and leads multiple funded research projects through 2028. Her research expertise spans several interconnected domains: Chronic Pain Mechanisms (100% research focus) Chronic Fatigue Syndrome/ME/CFS (91% research focus) Epigenetic Regulation in Pain Conditions (66% research focus) Central Nervous System Sensitization (86% research focus) Brain-Derived Neurotrophic Factor Pathways (47% research focus) Dr. Polli's recent publications demonstrate a sophisticated integration of molecular biology, immunology, and clinical pain research. Her 2025 work examines adrenergic dysfunction in ME/CFS, epigenetic mechanisms in pain management, and metabolic-immune interactions in chronic pain conditions. This research bridges basic science with clinical applications, particularly in developing evidence-based management strategies for complex chronic pain syndromes. She received recognition in 2022 for her work on stress intolerance mechanisms in chronic pain: Stress intolerance in patients with chronic widespread pain: are epigenetic mechanisms the answer to the mystery? Dr. Polli is actively involved in five major research projects investigating chronic pain mechanisms, including studies on low back pain comorbidities, epigenetic regulation of exercise-induced pain, stress-related mechanisms, and mitochondrial dysfunction in ME/CFS. Her collaborative network extends across multiple institutions, with significant activity in conference presentations and research supervision.

• Dialogical Approaches to Mental Health
• Community Mental Health
• Co-Production Research
• +۸ مورد دیگر

Dr. Anna Sidis is a Senior Lecturer at the University of Wollongong's School of Psychology within the Faculty of the Arts, Social Sciences and Humanities. With over 20 years of clinical experience as a Clinical Psychologist specializing in youth mental health, she holds dual appointments as both Senior Lecturer and Deputy Director of Postgraduate Psychology Programs (since January 2024). She serves as Chair of the Social Sciences Human Research Ethics Committee, demonstrating significant institutional leadership. Her educational background includes a Doctorate of Clinical Psychology (2001-2004) and Bachelor of Arts (Hons) from the University of Sydney. Her teaching portfolio spans undergraduate and postgraduate programs covering Family Therapy, Narrative Therapy, Psychosis assessment, Suicide Prevention, Grief counseling, and Critical Psychology. Dr. Sidis' research focuses on dialogical and community approaches to mental health care, with particular expertise in co-production methodologies, qualitative research, and critical psychology. Her work addresses critical areas including youth mental health, early psychosis intervention, suicide prevention, bereavement support (especially cancer-related grief), and service user involvement in care design. Analysis of her 22 publications reveals consistent emphasis on qualitative methodologies, therapist-client interaction dynamics, and innovative service delivery models like Open Dialogue. Her funded research includes projects examining barriers to mental health access for youth with co-morbid substance use, dialogical therapy implementation ('Always opening and never closing' grant), and community-based suicide prevention initiatives. She actively supervises five higher degree research students working on topics ranging from virtual reality exposure therapy to sports-based suicide prevention. Barriers to access and engagement of young people with co-morbid substance use (2022-2024) 'Always opening and never closing' dialogical therapy study (2022) Innovation and Evaluation Grant for youth mental health access (2022) Dr. Sidis maintains active clinical research networks through her role as Deputy Director of Postgraduate Programs and Ethics Committee leadership, while her 15 most recent publications demonstrate growing international impact with citations across multiple platforms including Wikipedia references and social media engagement.

• Population Genetics
• Evolutionary Biology
• Mathematical Biology
• +۵ مورد دیگر

Joachim Hermisson is a University Professor at the Medical University of Vienna, with dual appointments in the Faculty of Mathematics, Department of Mathematics, and at Max Perutz Labs, Department of Structural and Computational Biology. His research bridges mathematical theory and biological applications, focusing on population genetics and evolutionary dynamics. Professor Hermisson's primary research interests include: Population genetics theory and mathematical modeling Adaptive evolution and speciation processes Genetic architecture of quantitative traits Genomic signatures of selection Evolutionary rescue mechanisms Applications to medical conditions like ME/CFS His recent work demonstrates significant evolution from purely theoretical population genetics to increasingly interdisciplinary applications. During the 2008-2015 period, he established foundational frameworks for understanding speciation processes and adaptive evolution. His 2010 MSMS coalescent simulation program (300+ citations) became a standard tool in population genetics. From 2015-2020, he developed unifying frameworks for polygenic adaptation that connected selective sweeps with subtle frequency shifts. His 2020 Nature Reviews Genetics paper on this topic has garnered over 240 citations. More recently, he has expanded into medical applications, contributing to the D-A-CH consensus statement on ME/CFS diagnosis and treatment, and epidemiological modeling during the COVID-19 pandemic through EpiMath Austria. Professor Hermisson's scientific contributions have been widely recognized through high citation counts across his publications. His work appears consistently in top journals including Nature Reviews Genetics, PLoS Genetics, Evolution, and Genetics. His research methodology combines rigorous mathematical approaches with biological relevance, often bridging theoretical concepts with practical applications. Throughout his career, he has maintained active mentorship of junior researchers, with several frequent co-authors (Höllinger, Wölfl, Uecker, Kopp) likely representing former students who have developed into independent investigators. His collaborative approach spans mathematical theorists, computational biologists, and empirical researchers across multiple institutions.

Vyshali Manivannanمشاهده پروفایل

استادیار

• Disability Studies
• Chronic Pain and Fatigue
• Digital Multimodal Composition
• +۱۸ مورد دیگر

Vyshali Manivannan is an Assistant Professor in the Department of English, Writing, and Cultural Studies at Pace University – Pleasantville , within the Dyson College of Arts and Sciences . She holds a PhD in Communication, Information, and Media from Rutgers University, an MFA in Fiction Writing from Columbia University, and a BA in English from Dartmouth College. PhD : Rutgers University (2022) MFA : Columbia University (2007) BA : Dartmouth College (2005) Her research centers on disability studies, chronic pain, digital multimodal composition, intergenerational trauma , and decolonial praxis . She uses methodologies such as fictocritical autoethnography , digital repair play , and code-meshed transgenre writing to challenge academic ableism and Eurocentric rhetorical norms. Her work emphasizes accessible, socially just futures and critiques the biomedical complex and generative AI. Her recent publications and presentations explore topics like generative AI refusal, carework during the pandemic, and diasporic-disabled embodiment . Trends in her work show a consistent focus on the intersection of identity, technology, and marginalization , particularly through the lens of Eelam Tamil diaspora and chronic illness. Selected awards and honors include: Michelle Kendrick Award for Outstanding Digital Production/Scholarship (2023) Technology Innovator Award (2023) Rutgers Distinguished Scholarly Achievement Award (2023) Kairos Award for Graduate/NTT Faculty (2022) Pace LGBTQA+ Educator of the Year (2021) She is deeply committed to advising, accessible pedagogy, and institutional change. She directs the Writing-Enhanced Course (WEC) program and has received grants and recognition for her equity-focused teaching initiatives. Her Equitable Labor Statement and Enacting a Culture of Access address systemic inequities in academia. Dr. Manivannan is actively involved in disability justice movements and maintains an open-access digital portfolio. She co-edited a special issue on Carework and Writing During COVID and advocates for universal design, anti-ableist rhetoric, and accessible scholarship. Her lab is not a physical space but a conceptual and digital one centered on accessible composition, radical pedagogy, and social justice praxis .

Jeffrey Martinمشاهده پروفایل

استاد

• Kaposi's Sarcoma
• HIV-Associated Malignancies
• Clinical Research
• +۷ مورد دیگر

Jeffrey Martin is a Professor at the University of California San Francisco (UCSF) with over two decades of expertise in clinical research, epidemiology, and HIV-associated malignancies. He leads the UCSF Training in Clinical Research (TICR) Program and co-directs the Population and Clinical Sciences Core of the NIH-sponsored UCSF CFAR. His work spans observational and experimental studies in the U.S. and Africa, focusing on Kaposi’s sarcoma (KS), SARS-CoV-2, and immune dysregulation. He has directed large-scale cohorts like the UCSF SCOPE cohort and the Uganda AIDS Rural Treatment Outcomes (UARTO) Cohort , contributing to over 250 publications. Education includes a BA in Biology from Johns Hopkins University, an MD from the University of Pennsylvania, an MPH in Epidemiology from UC Berkeley, and fellowships in Infectious Diseases and AIDS Prevention at UCSF. His research in HIV-associated cancers, Long COVID, and viral immunology integrates study design, biostatistical analysis, and implementation science. Recent work explores SARS-CoV-2 antigen persistence, T cell dysfunction, and post-acute sequelae. He has pioneered diagnostic tools like KS-Detect for low-resource settings. Scientific Awards include the Phi Beta Kappa Alpha Omega Alpha Merck Manual Award New Investigator Award (UCSF CFAR) Stephen B. Hulley Award As PI or Co-PI on NIH grants such as U54CA254571 (USEAHAMRC) and R01CA119903 , he advances global health initiatives, mentoring junior researchers and managing multicenter collaborations like the East Africa IeDEA Consortium .

Sonja Coetzeeمشاهده پروفایل

مدرس

• Exercise Physiology
• Clinical Rehabilitation
• Chronic Disease Management
• +۶ مورد دیگر

Dr. Sonja Coetzee is a Lecturer in Clinical Exercise Physiology at the School of Health, University of the Sunshine Coast (UniSC). She specializes in evidence-based professional practice and applied clinical skills training, with a focus on musculoskeletal rehabilitation and chronic condition management. Her roles include practicum coordination for final-year Clinical Exercise Physiology students and supporting work-integrated learning (WIL) experiences. Prior to UniSC, she held academic positions at Southern Cross University (2012–2019) and North-West University, South Africa (2004–2011), where she also served as a practicing Biokineticist in the South African Military Health Service. Education: PhD Biokinetics (NWU), GradCert HEd (SCU), MSc (HMS), Honours in Biokinetics, BSc in Human Movement Sciences (all from NWU). Research Interests: Exercise as medicine for chronic conditions, musculoskeletal rehabilitation, body composition analysis, and aquatic therapy for ME/CFS and Parkinson’s Disease. Recent work includes studies on aquatic exercise programs for ME/CFS and cancer rehabilitation initiatives. Grants: Secured funding for projects like a six-month aquatic program for ME/CFS patients (A$100,000, 2018–2020) and a pilot study on aquatic interventions for ME/CFS (A$4,000, 2016–2017). Her teaching spans Exercise in Musculoskeletal Rehabilitation , Clinical Skills for Exercise Physiology , and practicum coordination. She is an accredited exercise physiologist and ISAK Level 3 Anthropometrist, emphasizing practical and clinical expertise in her academic work.

• Magnetic Resonance Spectroscopy
• Metabolic Imaging
• Energy Metabolism
• +۵ مورد دیگر

Ladislav Valkovič serves as Associate Professor of Metabolic Imaging at the University of Oxford's Radcliffe Department of Medicine and is a Fellow of Merton College. Holding a Sir Henry Dale Fellowship from the Wellcome Trust, he directs the Valkovič Group (Body MRS Group) within the Oxford Centre for Clinical Magnetic Resonance Research. His work pioneers ultra-high field (7T) magnetic resonance spectroscopy for non-invasive metabolic assessment in human heart, liver, and skeletal muscle, with applications in obesity, diabetes, and aging. Educational background includes a DSc, PhD, and Ing (Hons), though specific institutions and dates are not detailed in available sources. Valkovič's research centers on developing quantitative MRS techniques to measure energy metabolism and metabolic reaction rates. He focuses on methodological innovations for 7T MRI to overcome challenges like field inhomogeneities, enabling high-resolution spatial and temporal metabolic imaging. His work investigates how systemic diseases impact organ metabolism and evaluates exercise interventions for improving oxidative metabolism in elderly and metabolic disease populations. This research provides critical insights for therapeutic monitoring in cardiometabolic disorders. Recent publications demonstrate a strong emphasis on 7T MRS applications in Long COVID, ME/CFS, and obesity-related metabolic dysfunction. His work increasingly explores multi-organ interactions and mitochondrial impairments, particularly in post-viral syndromes. The consistent thread is method development for clinically feasible metabolic assessments that can translate to patient care. Key recognition includes: Sir Henry Dale Fellowship (Wellcome Trust) As a DPhil supervisor, Valkovič mentors students in metabolic imaging projects, currently offering opportunities in cardiac metabolism assessment. His research program is primarily funded by the Wellcome Trust fellowship, with additional support inferred from collaborative projects. He maintains active partnerships across Oxford and Central Europe for MRS technique development and exercise physiology studies. The Valkovič Group operates within Oxford's state-of-the-art MR research facility, leveraging a 7T scanner for phosphorus and proton spectroscopy. Collaborations span the Neubauer Group and international teams in Austria, Slovakia, and the Czech Republic, creating a robust network for advancing metabolic imaging science.

• Medicinal Chemistry
• Drug Discovery
• Cancer Pharmacology
• +۴ مورد دیگر

Peter Toogood is a distinguished medicinal chemist at the University of Michigan's College of Pharmacy, Department of Medicinal Chemistry, with a prolific 35+ year career in drug discovery. His research has significantly impacted cancer therapeutics, particularly through the development of selective kinase inhibitors. Dr. Toogood's research spans multiple therapeutic areas with a strong emphasis on cancer pharmacology and cell cycle regulation . His early work focused on bioorganic chemistry and natural products (azadirachtin insect antifeedants), evolving into targeted cancer therapies. He made seminal contributions to CDK4/6 inhibitor development, including the foundational work on PD 0332991 (palbociclib), which received FDA approval in 2015 for breast cancer treatment. Current research focuses on PDHK inhibitors for cancer metabolism and RORγ agonists for immuno-oncology applications. Analysis of his publication trends reveals a strategic evolution from natural product chemistry to targeted kinase inhibitors, with increasing focus on cancer metabolism and immunotherapy in recent years. His work demonstrates exceptional translational impact, with multiple compounds advancing to clinical development. Dr. Toogood has collaborated extensively across disciplines, working with biologists, pharmacologists, and clinicians to validate therapeutic targets and develop novel agents. His research has been supported by both NIH grants and pharmaceutical partnerships.

• Inflammatory Bowel Disease (IBD)
• Gastroenterology
• Fecal Microbiota Transplantation (FMT)
• +۷ مورد دیگر

Rasmus Goll is a Professor at the Department of Clinical Medicine at UiT The Arctic University of Norway. He leads the Gastroenterology and Nutrition (GNU) research group and is involved in projects like Advanced Study of Inflammatory Bowel Disease (ASIB) . His work focuses on inflammatory bowel diseases, gut microbiome, and translational research for precision medicine. Department: Clinical Medicine (UiT The Arctic University of Norway) Research Group: Gastroenterology and Nutrition (GNU) Key Collaborators: Jon Florholmen, Guanglin Cui, Joseph Diab, Terkel Hansen Holds a ORCID ID 0000-0003-4375-0509 and has published extensively on topics including fecal microbiota transplantation (FMT), metabolomics, lipidomics, and biomarker development for ulcerative colitis and neuroendocrine tumors. His recent articles (2025–2021) span clinical trials on FMT in obesity, lipidomic studies in refractory IBD, and neuroendocrine tumor biomarkers. Current projects include a 2024 BMJ Open trial protocol for FMT in ME/CFS patients, and 2023–2019 studies on: Obesity and metabolic syndrome (leptin/adiponectin ratios) IBD quality of life comparisons (nurse-led vs conventional care) Helicobacter pylori antibiotic resistance Colorectal cancer microenvironment (ST2, IL-17A, TH17 cells) Mucosal gene expression in UC remission Calprotectin kit comparisons for UC monitoring

• Sports Science
• Exercise Physiology
• Clinical Sciences
• +۲ مورد دیگر

Dr. Giselle Allsopp is a Lecturer in Human Physiology at Deakin University, within the School of Exercise and Nutrition Sciences in the Faculty of Health. She is affiliated with the Institute for Physical Activity and Nutrition and is based at the Geelong Waurn Ponds Campus. Her research focuses on the intersection of exercise physiology, immunology, and aging. Key areas of investigation include: Physiological responses to resistance training under normobaric hypoxia conditions Effects of hypoxia on muscle strength and mass adaptations in older adults Leukocyte and inflammatory cytokine responses to exercise in aging populations Hormonal and metabolic adaptations to resistance training Applications of blood flow restriction training for muscle hypertrophy Dr. Allsopp's work demonstrates a strong emphasis on understanding how environmental stressors like hypoxia affect physiological responses to exercise, particularly in older adult populations. Her research combines laboratory-based experimental approaches with clinical applications to enhance exercise prescription for various populations. Dr. Allsopp currently supervises doctoral student Elham Yaghoobi, whose research focuses on Krill Oil supplementation and its effects on pain reduction and recovery from muscle-damaging exercise. Her research has been supported by multiple grants, including: "Mussels as a snack option to increase the omega-3 index and markers of recovery in female endurance athletes" (Fisheries Research & Development Corporation, 2025-2026) "ALMOND ProFIT-PM: Almond protein powder to enhance fitness training adaptations in postmenopausal women" (Almond Board of California, 2024-2025) "Can dietary supplementation with Krill-Oil improve ME/CFS symptoms?" (Equity Trustees, 2022-2025)

Alex Todhunter-Brownمشاهده پروفایل

استاد

• Stroke Rehabilitation
• Systematic Reviews in Healthcare
• Neurological Disorders
• +۳ مورد دیگر

Alex Todhunter-Brown is a Professor in the Department of Nursing at Glasgow Caledonian University. His research focuses on stroke rehabilitation, chronic disease management, and systematic reviews in healthcare. He leads major projects including the SPRUCE Cochrane review and the NIHR Evidence Synthesis Programme, emphasizing evidence-based practices. His work contributes to UN Sustainable Development Goals related to health and well-being. Key roles: Principal Investigator (PI) on multiple funded projects Research collaborations: Cochrane Stroke Group, University of Stirling, Monash University Key areas: Stroke recovery, multimorbidity, ME/CFS evidence mapping Recent articles highlight his work on post-stroke mobility, vascular disease exercise interventions, and chronic conditions evidence synthesis. He has authored over 130 peer-reviewed publications with significant citations. Grants/Projects: Includes £M funding for stroke rehabilitation (SPRUCE), chronic constipation in children (SUCCESS), and GRADE methodology development. He oversees interdisciplinary teams addressing global health challenges through rigorous evidence synthesis. Labs/Initiatives: Active in the Cochrane Stroke Group and NIHR Evidence Synthesis Scotland, advancing clinical guidelines and healthcare policies.